Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cellceutix CTIX

Healthcare Biotechnology
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:CTIX)

Cellceutix Announces Company Name Change to Innovation Pharmaceuticals Inc.

GlobeNewswire June 7, 2017

Cellceutix Anti-Cancer Drug Candidate’s p53 Activity in Acute Myeloid Leukemia to be Presented by Independent Researchers at the 2017 European Hematology Association Annual Meeting

GlobeNewswire May 30, 2017

Cellceutix Completes Patient Enrollment of Final Cohort in Phase 2 Trial of Brilacidin for Inflammatory Bowel Disease; Topline Results Anticipated in July

GlobeNewswire May 18, 2017

Cellceutix Provides Corporate Update; Significant Milestones Ahead as Multiple Mid-Phase Clinical Trials Set to Conclude

GlobeNewswire May 10, 2017

Cellceutix Announces Details for Upcoming Investor and Shareholder Presentations

GlobeNewswire April 19, 2017

Cellceutix CEO Discusses Brilacidin Following Interim Trial Results for Treating Oral Mucositis and Inflammatory Bowel Disease

GlobeNewswire April 10, 2017

Cellceutix AACR Poster Presents Data Supporting Kevetrin Modulation of p53 in Multiple Human Ovarian Cancer Cell-lines and Corresponding Xenograft Tumors

GlobeNewswire April 3, 2017

Cellceutix Reports Very Encouraging Interim Analysis of Phase 2 Drug Candidate Brilacidin for Severe Oral Mucositis (OM) in Head and Neck Cancer Patients; High Potential for Preventative Treatment

GlobeNewswire March 27, 2017

Cellceutix Releases Favorable Topline Findings as Part of Interim Analysis of Phase 2 Drug Candidate Brilacidin for the Treatment of Inflammatory Bowel Disease

GlobeNewswire March 21, 2017
View More News ››

Opinion & Analysis (GREY:CTIX)

The Calandra Report: More biotech, Bitterroot, CTIX, BCRX, CUR and more

Thom Calandra January 14, 2014
View More Opinion ››

Bullboard Posts (GREY:CTIX)

RE:RE:RE:RE:RE:Question.

If there was any concerns by alpha. the lawyers have back off big time in their persuit of inproprieity
rainman8945 - November 27, 2015

RE:RE:RE:RE:Question.

stay the course, funding is there. there is a major shorter who has jerked ctix arounf. braciadin is getting ready to stary phase 3. So...
tennisman - November 3, 2015

Hard to believe ...

With all the positive possibilities that it hasn't moved to the big board or even gotten more analysts coverage.
Seamusknows1972 - November 27, 2014

Not a very active forum...

... Stock seems to be doing well though.
WCoyote - October 26, 2014

Baffled indeed...

I appreciate your stories however I'm looking for "meat and potatoes" facts. It seems as though volume is picking up...
Seamusknows1972 - May 12, 2014

RE:RE:Question.

Thanks for your thoughts and info. I'm just trying to gather information beyond what you've suggested as well as other investor...
Seamusknows1972 - May 4, 2014
View more Bullboard ››

Eastern Platinum Ltd.

Eastern Platinum Ltd.

Eastern Platinum Limited owns directly and indirectly a number of platinum group metals (PGM) and chrome assets in the ...
View More »